Part 1/5:
Surge in Stock Prices for Novo Nordisk and Eli Lilly Following Biden’s Proposal
On Tuesday, shares of pharmaceutical giants Novo Nordisk and Eli Lilly experienced a noticeable surge, driven by investors' optimism following a significant healthcare proposal from U.S. President Joe Biden. This proposal centers on expanding coverage for anti-obesity medications to millions of Americans enrolled in Medicare and Medicaid.